A Filipino-owned company is putting up a multibillion-peso facility that will manufacture the “next generation” coronavirus disease 2019 (Covid-19) vaccine.
Giovanni Alingog, chief executive officer of Glovax Biotech Corp., aims to build a production plant either in Subic in Zambales or Clark in Pampanga.
Already have an active account? Log in here.
Keep reading with one of these options:
Keep reading with one of these options:
Premium Subscription
Less than P 71 per month
(billed annually at P 850)
(billed annually at P 850)
- Unlimited ad-free access to website articles
- Access to subscriber exclusive website contents
- Access to the Digital Edition (up to 3 devices)
TRY FREE FOR 30 DAYS
Digital + Print
P 740 per month
(billed annually at P 8,880)
(billed annually at P 8,880)
- Ad-free online access
- Access to the Digital Edition
- Print copies**
***Delivery charges may apply to subscribers outside of Metro Manila
(No free trial for this plan)